An anticancer drug to probe non-specific protein-DNA interactions

Phys Chem Chem Phys. 2014 Mar 7;16(9):3914-7. doi: 10.1039/c3cp54422b.

Abstract

A visible fluorescence switch of an eminent anti-carcinogen, ellipticine has been used to probe non-specific protein-DNA interaction. The unique pattern of protein-DNA complexation is depicted for the first time through field emission scanning electron microscopy (FE-SEM) images and spectroscopic techniques.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology
  • Cattle
  • DNA / chemistry*
  • DNA / metabolism
  • Ellipticines / chemistry*
  • Ellipticines / pharmacology
  • Fluorescence Resonance Energy Transfer
  • Protein Binding / drug effects
  • Proteins / chemistry*
  • Proteins / metabolism
  • Serum Albumin / chemistry
  • Serum Albumin / metabolism
  • Serum Albumin, Bovine / chemistry
  • Serum Albumin, Bovine / metabolism

Substances

  • Antineoplastic Agents
  • Ellipticines
  • Proteins
  • Serum Albumin
  • ellipticine
  • Serum Albumin, Bovine
  • DNA
  • calf thymus DNA